CBC Interpretation: Concerning for Hematologic Malignancy Requiring Urgent Evaluation
This CBC demonstrates leukocytosis with left shift, immature granulocytes, nucleated RBCs, normocytic anemia with elevated RDW, and relative lymphopenia—a constellation highly suspicious for a myeloproliferative neoplasm, most likely chronic myeloid leukemia (CML), requiring immediate peripheral smear review, BCR-ABL1 testing, and hematology consultation. 1, 2
Critical Abnormalities Identified
White Blood Cell Abnormalities
- WBC 17.3 × 10⁹/L with neutrophilia (73.5%, absolute 12.8 × 10⁹/L): This moderate leukocytosis with neutrophil predominance falls below the typical CML threshold of >25 × 10⁹/L but exceeds normal limits and warrants investigation 2, 3
- Immature granulocytes 1.8% (0.3 × 10⁹/L absolute): The presence of immature granulocytes in peripheral blood is abnormal and indicates either severe physiologic stress or an underlying myeloproliferative neoplasm 2
- Nucleated RBCs 1.7% (0.3 × 10⁹/L absolute): This is a critical finding suggesting bone marrow stress, extramedullary hematopoiesis, or marrow infiltration 2
- Relative lymphopenia (8.5%, absolute 1.5 × 10⁹/L): The disproportionately low lymphocyte percentage in the setting of leukocytosis suggests a myeloid-predominant process 4
Red Blood Cell Abnormalities
- Severe normocytic anemia: Hemoglobin 8.1 g/dL, hematocrit 26.3%, RBC 2.90 × 10¹²/L with normal MCV (90.7 fL) indicates anemia of chronic disease or bone marrow failure 5
- Elevated RDW 18.6%: This suggests heterogeneous red cell populations, consistent with ongoing marrow stress or dysplasia 4
Other Findings
- Monocytosis: Absolute monocyte count 1.6 × 10⁹/L (≥1.0 × 10⁹/L threshold) requires evaluation for chronic myelomonocytic leukemia (CMML) or other myeloid neoplasms 6
- Eosinophilia: Absolute eosinophil count 1.1 × 10⁹/L is elevated and may accompany CML 2
- Basophilia: Absolute basophil count 0.2 × 10⁹/L—while only mildly elevated, basophilia ≥200/mm³ strongly suggests CML rather than reactive causes 2
Differential Diagnosis
Primary Concern: Chronic Myeloid Leukemia
CML is the leading diagnosis based on the following features 1, 2:
- Left shift with immature granulocytes representing the full spectrum of myeloid maturation 2
- Basophilia and eosinophilia accompanying the leukocytosis 2
- Nucleated RBCs indicating marrow stress 2
- Normocytic anemia consistent with CML presentation 5
Key distinguishing features from the typical CML presentation 1:
- WBC is only 17.3 × 10⁹/L rather than the characteristic >100 × 10⁹/L seen in most CML cases
- However, CML can present with lower WBC counts, and the qualitative findings (immature granulocytes, basophilia, eosinophilia, nucleated RBCs) are more diagnostically significant than the absolute WBC count 5, 2
Alternative Considerations
Chronic Myelomonocytic Leukemia (CMML): The monocytosis (1.6 × 10⁹/L) raises concern for CMML, which requires persistent monocytosis with dysplasia and <20% blasts 6
Reactive Leukocytosis: Less likely given the combination of immature granulocytes, nucleated RBCs, and multiple cell line abnormalities 3, 7
- Infections typically cause leukocytosis with toxic granulations but not nucleated RBCs 3
- Adult-onset Still's disease can cause WBC >15 × 10⁹/L with neutrophilia but would not explain the immature granulocytes and nucleated RBCs 5, 6
Acute Myeloid Leukemia (AML): Less likely because AML typically presents with circulating blasts, more severe cytopenias, and lacks the orderly myeloid maturation seen here 1
Immediate Diagnostic Workup Required
Urgent Laboratory Studies
- Manual peripheral blood smear review to confirm automated differential, assess myelocyte proportion, evaluate for dysplasia, and identify any blasts 2, 4
- BCR-ABL1 testing by RT-PCR: This is diagnostic for CML and must be performed immediately 5, 2
- Repeat CBC with manual differential to document percentages of all immature forms (blasts, promyelocytes, myelocytes, metamyelocytes) 2
Bone Marrow Evaluation
Bone marrow aspiration and biopsy are mandatory given the constellation of findings 2, 6:
- Assess marrow cellularity and blast percentage 6
- Conventional cytogenetic analysis to detect Philadelphia chromosome t(9;22) 5, 2
- FISH for BCR-ABL1 if cytogenetics cannot be analyzed 5
- Gomori silver staining to assess for reticulin fibrosis (present in 30% of CML cases) 5
Additional Testing
- Molecular testing: If BCR-ABL1 is negative, test for PDGFRA/PDGFRB rearrangements (given eosinophilia) and mutations in TET2, SRSF2, ASXL1, and RAS genes to evaluate for CMML 6
Clinical Context Assessment
History to Obtain
- Constitutional symptoms: Weight loss, night sweats, fever, fatigue (present in 40-50% of CML cases) 1
- Splenomegaly symptoms: Early satiety, left upper quadrant fullness (splenomegaly in 40-50% of CML) 1
- Bleeding or bruising: Suggests thrombocytopenia or coagulopathy 5
- Infection symptoms: To exclude reactive causes 3
- Medication history: Corticosteroids, lithium, beta-agonists can cause reactive leukocytosis 7
Physical Examination
- Splenomegaly: Most consistent finding in CML, present in 40-50% at diagnosis 1
- Hepatomegaly: Less common but characteristic 1
- Lymphadenopathy: Evaluate for lymphoproliferative disorders 6
Red Flags for Disease Progression
The following findings would indicate accelerated or blast phase CML 5:
- Blasts 15-29%: Accelerated phase by European LeukemiaNet criteria 2
- Blasts ≥30%: Blast phase 2
- Basophils >20%: Suggests progression 5, 2
- Platelets <100 × 10⁹/L unrelated to therapy: Accelerated phase criterion 5
Urgent Hematology Consultation Indicated
Immediate hematology referral is mandatory based on 2, 4:
- Immature granulocytes with WBC >15 × 10⁹/L
- Nucleated RBCs in peripheral blood
- Concurrent basophilia and eosinophilia
- Unexplained normocytic anemia with elevated RDW
- Monocytosis requiring evaluation for CMML
Common Pitfalls to Avoid
- Do not attribute this to infection alone: While infections cause leukocytosis, the presence of nucleated RBCs, immature granulocytes, and basophilia suggests a primary marrow disorder 3, 4
- Do not delay BCR-ABL1 testing: This is the definitive diagnostic test for CML and should be ordered immediately 5, 2
- Do not rely solely on WBC count: The qualitative findings (cell types present) are more important than the absolute WBC count for diagnosing myeloproliferative neoplasms 2, 4
- Do not miss CMML: The monocytosis requires specific evaluation with bone marrow examination if it persists 6